Mandybur T I, Ormsby I, Buncher C R
Cancer Res. 1978 Oct;38(10):3182-5.
Transplacental and neonatal induction of mammary tumors (MT's) with ethylnitrosourea (ENU) was studied in Sprague-Dawley rats. A low transplacental ENU dose (10 mg/kg) did not increase the number of MT's or shorten their latency period. High ENU doses (30 mg/kg neonatal, 60 mg/kg transplacental, or 120 mg/kg transplacental) when corrected for differences in life span caused a significant shortening of the tumor induction period and an overall increase in the tumor incidence. With high ENU doses, the MT's were frequently multiple in the same animal and were more often malignant. Tumors developed mostly in females; only a few were observed in males. It is concluded that with a sufficient dose of the carcinogen in susceptible animals, transplacental and neonatal ENU mammary carcinogenesis takes place. The experiment was originally designed to evaluate ENU-induced neurogenic tumors; the results on MT's were obtained incidentally.
在斯普拉格-道利大鼠中研究了用乙基亚硝基脲(ENU)经胎盘和新生儿诱导乳腺肿瘤(MT)。低剂量经胎盘ENU(10毫克/千克)并未增加MT的数量或缩短其潜伏期。当校正寿命差异时,高剂量ENU(新生儿30毫克/千克、经胎盘60毫克/千克或经胎盘120毫克/千克)导致肿瘤诱导期显著缩短且肿瘤发生率总体增加。使用高剂量ENU时,同一动物体内的MT通常为多发性,且更常为恶性。肿瘤大多发生在雌性动物中;雄性动物中仅观察到少数。结论是,在易感动物中给予足够剂量的致癌物时,经胎盘和新生儿ENU可引发乳腺癌变。该实验最初旨在评估ENU诱导的神经源性肿瘤;关于MT的结果是偶然获得的。